NeuroBo Pharmaceuticals, Inc.
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 cli…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
NeuroBo Pharmaceuticals, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
NeuroBo Pharmaceuticals, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of NeuroBo Pharmaceuticals, Inc..